BIOCYTEX – Trademark Portfolio

Entity Type: 99

BIOCYTEX holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include REDQUANT and CELLQUANT. The owner is based in MARSEILLE.

140, chemin de l'Armée d'Afrique

MARSEILLE F-13010 , FR

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

BIOCYTEX's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does BIOCYTEX have?

BIOCYTEX has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 1 cancelled.

What trademark classes does BIOCYTEX file in?

BIOCYTEX files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are BIOCYTEX's most well-known trademarks?

BIOCYTEX's registered trademark portfolio includes well-known marks such as REDQUANT and CELLQUANT. These are among 2 currently registered trademarks in the portfolio.

What is BIOCYTEX's trademark registration success rate?

BIOCYTEX has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.